Curr Med Res Opin 26571-588van Ingen J Aarnoutse RE Donald PR et al 2011 Why do we use 600 mg of rifampicin in tuberculosis treatment Clin Infect Dis 52e194-e199DeMarco VP Ordonez AA Klunk M et al 2015 Determination of 11Crifampin pharmacokinetics within Mycobacterium tuberculosis- infected mice by using dynamic positron emission tomography bioimaging.

Ning et al.

and Gowrishankar et al.

Weinstein and Ordonez et al.

Similarly Santangelo et al.

Finally using endogenous CEST contrast Liu et al.

Recently Chen et al.

J Infect 55254-259McGann P Snesrud E Maybank R et al 2016 Escherichia coli Harboring mcr-1 and blaCTX-M on a novel IncF plasmid first report of mcr-1 in the United States.

Antimicrob Agents Chemother 604420-4421Liu YY Wang Y Walsh TR et al 2016 Emergence of plasmid- mediated colistin resistance mechanism MCR-1 in animals and human beings in China a microbiological and molecular biological study.

Lancet Infect Dis 16161-168Magill SS Edwards JR Bamberg W et al 2014 Multistate point- prevalence survey of health care-associated infections.

